Al joined Theracos in July 2009 as President and CEO. Theracos is a privately held company that is transitioning from a development stage company to a commercial stage company with the upcoming filing of its NDA for bexagliflozin, a highly specific SGLT-2 inhibitor for the treatment of Type 2 Diabetes.He has extensive experience in the biotechnology and pharmaceutical industries and has held senior positions in large and small, public and private companies.
Prior to joining Theracos, Al served as Chief Business Officer at Rib-X Pharmaceuticals and was formerly VP Global R&D Licensing at BASF Pharma. He received his Ph.D. in biochemistry from Brandeis University after attending both University of Hawaii and University of Rhode Island. Al was formerly a post-doctoral fellow at Dana-Farber Cancer Institute and Harvard Medical School.
- Primary/Complementary Interactive Styles: Warrior/Expert-Mastermind
- Interactive Combination: The Sage/The Power Broker
- In a film, he’d be played by: Robert DeNiro
- Common Leadership Characteristic: Great depth of knowledge of product and process
